Get started
Live feed
·
INSIDERFilingvia Quantisnow
TRACON Pharmaceuticals Inc. logo

SEC Form 4: Opaleye Management Inc. bought $3,877 worth of shares (2,254 units at $1.72)

ByQuantisnow·Wall Street's wire, on your screen.
TCONTRACON Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCON (TRACON Pharmaceuticals Inc.) and more on Quantisnow.